Masahisa Hashimoto

834 total citations
58 papers, 700 citations indexed

About

Masahisa Hashimoto is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Masahisa Hashimoto has authored 58 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Masahisa Hashimoto's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Masahisa Hashimoto is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Masahisa Hashimoto collaborates with scholars based in Japan and United States. Masahisa Hashimoto's co-authors include Hisashi Miyazaki, Satoshi Arakawa, Shigeru Kurooka, Yutaka Sekine, Toshikazu Yamaguchi, Toshihiko Fujii, Kōji Yoshida, Kiyoshi Nakamura, Donald C. Davis and James R. Gillette and has published in prestigious journals such as The Journal of Chemical Physics, Journal of Chromatography A and Biochemical Pharmacology.

In The Last Decade

Masahisa Hashimoto

57 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahisa Hashimoto Japan 17 292 119 109 106 102 58 700
J.J. Vallner United States 15 399 1.4× 139 1.2× 159 1.5× 194 1.8× 73 0.7× 46 941
Taro Ogiso Japan 18 328 1.1× 85 0.7× 80 0.7× 58 0.5× 108 1.1× 92 1.1k
Hideyo Noguchi Japan 17 190 0.7× 165 1.4× 88 0.8× 143 1.3× 128 1.3× 55 774
Noboru Yata Japan 21 469 1.6× 142 1.2× 201 1.8× 72 0.7× 163 1.6× 95 1.3k
S. Higuchi Japan 12 172 0.6× 127 1.1× 111 1.0× 94 0.9× 115 1.1× 34 605
R. Obach Spain 19 217 0.7× 112 0.9× 131 1.2× 119 1.1× 79 0.8× 60 1.1k
Elke Schmidt Germany 16 335 1.1× 57 0.5× 118 1.1× 151 1.4× 111 1.1× 26 845
Bruce N. Tattam Australia 17 169 0.6× 78 0.7× 107 1.0× 66 0.6× 97 1.0× 30 921
G. R. Gordon United States 16 190 0.7× 65 0.5× 121 1.1× 38 0.4× 110 1.1× 41 645
ATSUKO NODA Japan 15 133 0.5× 54 0.5× 67 0.6× 111 1.0× 164 1.6× 71 623

Countries citing papers authored by Masahisa Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Masahisa Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahisa Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahisa Hashimoto more than expected).

Fields of papers citing papers by Masahisa Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahisa Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahisa Hashimoto. The network helps show where Masahisa Hashimoto may publish in the future.

Co-authorship network of co-authors of Masahisa Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masahisa Hashimoto. A scholar is included among the top collaborators of Masahisa Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahisa Hashimoto. Masahisa Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohue, Tomio, et al.. (1991). ABSORPTION, DISTRIBUTION AND EXCRETION OF SPARFLOXACIN IN ANIMALS. 39(4). 123–130. 2 indexed citations
2.
Miyazaki, Hisashi, et al.. (1991). Pharmacokinetics of Haloperidol Decanoate in Rats.. Journal of Pharmacobio-Dynamics. 14(11). 615–622. 11 indexed citations
3.
Mizuki, Yasuyuki, Toshikazu Yamaguchi, Yutaka Sekine, & Masahisa Hashimoto. (1991). Effect of sparfloxacin on pharmacokinetics of theophylline in rats.. Drug Metabolism and Pharmacokinetics. 6(1). 67–72. 3 indexed citations
4.
Miyazaki, Hisashi, et al.. (1989). Binding of sulfonamides to erythrocytes and their components.. Chemical and Pharmaceutical Bulletin. 37(7). 1913–1915. 22 indexed citations
5.
Yamada, Masaaki, et al.. (1989). Interleukin-1α: Its possible roles in cancer therapy. Biotherapy. 1(4). 327–338. 9 indexed citations
6.
Miyazaki, Hisashi, et al.. (1989). Mode of antitumor action of recombinant human tumor necrosis factor on the sarcoma Meth A transplanted in the mouse. Biotherapy. 1(1-2). 47–57. 1 indexed citations
7.
Fujii, Toshihiko, et al.. (1987). Disposition and metabolism of (14C)cadralazine in rats. (I). Single administration.. Drug Metabolism and Pharmacokinetics. 2(6). 587–603. 1 indexed citations
8.
Miyazaki, Hisashi, et al.. (1987). Hydrolysis of haloperidol decanoatein vitro by cultured cells. European Journal of Drug Metabolism and Pharmacokinetics. 12(3). 183–188. 3 indexed citations
9.
Terauchi, Yoshiaki, et al.. (1987). Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay.. Journal of Pharmacobio-Dynamics. 10(12). 758–766. 1 indexed citations
10.
Fujii, Toshihiko, et al.. (1984). Disposition and metabolism of [14c]at-2266 I. single administration. Chemotherapy. 32. 117–135. 4 indexed citations
11.
Fujii, Toshihiko, et al.. (1984). . RADIOISOTOPES. 33(8). 519–525. 8 indexed citations
12.
Miyazaki, Hisashi, et al.. (1983). Simultaneous determination of plasma and urinary uric acid, xanthine, hypoxanthine, allopurinol, oxipurinol, orotic acid, orotidine and creatinine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 274. 75–85. 27 indexed citations
13.
Sekine, Yutaka, et al.. (1982). . NIPPON SUISAN GAKKAISHI. 48(11). 1599–1608. 5 indexed citations
14.
Sekine, Yutaka, et al.. (1980). Determination of haloperidol in human serum by radioimmunoassay.. Journal of Pharmacobio-Dynamics. 3(5). 250–257. 12 indexed citations
15.
Miyazaki, Hisashi, et al.. (1979). Disposition and metabolism of [14C]loperamide in rats. European Journal of Drug Metabolism and Pharmacokinetics. 4(4). 199–206. 17 indexed citations
16.
Miyazaki, Hisashi, et al.. (1978). Distribution of 14C-Pipemidic Acid in the Guinea Pig Ear. RADIOISOTOPES. 27(3). 135–138. 2 indexed citations
18.
Kurooka, Shigeru, et al.. (1976). Relationship between the Structures of S-Acyl Thiol Compounds and Their Rates of Hydrolysis by Pancreatic Lipase and Hepatic Carboxylic Esterase. The Journal of Biochemistry. 79(3). 533–541. 16 indexed citations
19.
Sekine, Yutaka, et al.. (1976). Metabolism of piromidic acid, a new antibacterial agent. II. In vitro metabolic pathway of piromidic acid in rats.. Chemical and Pharmaceutical Bulletin. 24(3). 437–442. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026